Current Clinical Trials

Thoracic and lung specialized cancer research program

To inquire about ongoing thoracic and lung cancer clinical trials, please reach  the clinical research team on 01-350000 Ext: 5110,  7804 or 7803

Ongoing thoracic and lung cancer clinical trials:

Lung – Respiratory cancers:

PI: Arafat Tfayli

  • CJDQ443B12301/BIO-2022-0145: A randomized, controlled, open label, phase III study evaluating the efficacy and safety of JDQ443 versus docetaxel in previously treated subjects with locally advanced or metastatic KRAS

 

  • BIO-2023-0355/ MO42720: Assessing the impact of digital patient monitoring on health outcomes and healthcare resource usage in addition to the feasibility of its combination with at-home treatment, in participants receiving systemic anticancer treatment in clinical practice: protocol for an interventional, open-label, multicountry platform study

 

 


QUICK LINKS

 

NKBCI HOME

PATIENT RESOURCES

CANCER SUPPORT FUND

DONATE BLOOD

NKBCI NEWSLETTER

CONTACT US